The role of immunoscintigraphy in the staging and management of colorectal cancer

American Surgeon

Volumn 62, Issue 11, 1996, Pages 956-960

  Doerr, Ralph J ^a,b   Kulaylat, Mahmoud N ^a   Bumpers, Harvey ^a   Abdel Nabi, Hani ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; COLON ADENOCARCINOMA; COLORECTAL CANCER; HUMAN; IMMUNOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; OCCULT CANCER; RECTUM CARCINOMA;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; RADIOIMMUNODETECTION;

EID: 0029907570     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995;45:8-30.
2. Cady B, Stone MD, Wayne J. Continuing trends in the prevalence of right-sided lesions among colorectal carcinomas. Arch Surg 1993;128:505-9.
3. Wood DA, Robbins GF, Zippin C, et al. Staging of cancer of the colon and cancer of the rectum. Cancer 1979;43:961-8.
4. Steele GD Jr, Winchester DP, Menck HR, Murphy GP. Clinical highlights from the National Cancer Data Base: 1993. CA Cancer J Clin 1993;43:71-82.
5. Osnes S. Carcinoma of the colon and rectum. A study of 353 cases with special reference to prognosis. Acta Chir Scand 1955; 110:378-83.
6. Freeny PC, Machs WM, Ryan JA, Bolen JW. Colorectal carcinoma evaluation with CT preoperative staging and detection of postoperative recurrence. Radiology 1986:158:347-59.
7. Soyer P, Levesque M, Elias D, et al. Detection of liver métastases from colorectal cancer: Comparison of intraoperative US and CT during arterial portography. Radiology 1992;183:54144.
8. Guinet C, Buy JN, Sezeur A, et al. Preoperative assessment of the extension of rectal carcinoma: Correlation of MR', surgical, and histopathologic findings. J Comput Assist Tomogr 1988;12: 209-14.
9. Rathenberger DA, Wong DW. Preoperative assessment of patients with rectal cancer. In: Seminars in Colon and Rectal Surgery, Veidenheimer MC, ed. Philadelphia: WB Saunders, 1990, pp 2-10.
10. Boyce GA, Sivak MV. New approaches to the diagnosis of malignant and premalignant lesions: Colonoscopic endosonography and laser-induced fluorescence spectroscopy. In: Seminars in Colon and Rectal Surgery, Veidenheimer MC, ed. Philadelphia: WB Saunders, 1991, pp 17-21. "
11. Doerr RJ, Abdel-Nabi H, Baker JM, Steinberg S. Detection of primary colorectal cancer with Indium-111 monoclonal antibody B72.3. Arch Surg 1990; 125:1601-5.
12. Haseman MK. Monoclonal antibody imaging of colorectal and ovarian cancer. West J Med 1994;161:412.
13. Kim SL, Goldschmid S. Monoclonal antibody imaging in colon cancer: A transition from basic science to clinical application. Am J Gastroenterol 1994;89:1910-2.
14. Kühn JA, Thomas G. Monoclonal antibodies and colorectal carcinoma: A clinical review of diagnostic applications. Cancer Invest 1994;12:314-23.
15. Rosemurgy AS, Block GE, Shihab F. Surgical treatment of carcinoma of the abdominal colon. Surg Gynecol Obstet 1988;167: 399-406.
16. Beatty JD, Hyams DM, Morton BA, et al. Impact of radiolabeled antibody imaging on management of colon cancer. Am J Surg 1989;157:13-9.
17. Thompson WM, Halvorsen RA. Computed tomographic staging of gastrointestinal malignancies. II. Invest Radiol 1987;22: 96-105.
18. Cass AW, Million RR, Pfaff WW. Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum. Cancer 1976;37:2861-5.
19. Polk HC, Spratt JS. Recurrent colorectal carcinoma: Detection, treatment, and other considerations. Surgery 1971;69:9-15.
20. Galandiuk S, Wieand HS, Moertel CG, et al. Patterns of recurrence after curative resection of carcinoma of the colon and resection. Surg Gynecol Obstet 1992;174:27-32.
21. Montges B, Bruchner R. Das kolekarzinom: Prognostische faktorem. Dtsch Med Wochenschr 1986;! 1:1790-8.
22. Adson MA, VanHeerden JA, Adson MH. Resection of hepatic metastasis from colorectal cancer. Arch Surg 1981;! 19: 647-54.
23. Cady B, McDermott WV. Major hepatic resection for metachronous metastasis from colon cancer. Ann Surg 1985;201: 204-9.
24. Iwatsuki S, Shaw BW, Storzl TE. Experience with 150 liver resections. Ann Surg 1983;197:247-56.
25. Steele G Jr, Bleday R, Mayer RJ, et al. A prospective evaluation of hepatic resection for colorectal carcinoma métastases to the liver: Gastrointestinal tumor study group protocol 6584. JClinOncol 1991;9:1105-12.
26. Abdel-Nabi H, Doerr RJ, Him-Wang C, et al. Safety and role of repeated administrations of In-111 labeled anti carcinoembryonic antigen monoclonal antibody ZCE-025 in the postoperative follow-up of colorectal carcinoma patients. J Nucl Med 1992;33:14-22.
27. Kulaylat M, Doerr RJ, Abdel-Nabi H. Preliminary results of repeat infusion of indium-Ill CYT-103 monoclonal antibody in recurrent colorectal cancer. Society of Surgical Oncology, Los Angeles, CA, March 18, 1993 (Abstract).
28. Doerr RJ, Abdel-Nabi H, Krag D, Mitchell E. Radiolabeled antibody imaging in the management of colorectal cancer: Results of a multicenter clinical study. Ann Surg 1991;214:118-24.
29. German ML, Galandiuk S, Block GE, Prager ED, Weiner GJ, Kahn D, Abdel-Nabi H, et al. Immunoscintigraphy with "'Insatumomab pendetitide in patients with colorectal adenocarcinoma: Performance and impact on clinical management. Dis Colon Rectum 1994;37:129-37.